Literature DB >> 18057958

ABCB1 (P-glycoprotein) but not ABCC1 (MRP1) is downregulated in peripheral blood mononuclear cells of spontaneously hypertensive rats.

Raphael C Valente1, Luiz S Capella, Clarissa R Nascimento, Filipe Braga, Juliana Echevarria-Lima, Aníbal G Lopes, Márcia A M Capella.   

Abstract

Although the kidney is a major target in hypertension, several studies have correlated important immune alterations with the development of hypertension in spontaneously hypertensive rats (SHR), like increased secretion of pro-inflammatory cytokines, inflammatory infiltration in kidneys and thymic atrophy. Because adenosine-triphosphate-binding cassette sub-family B member 1 (ABCB1; P-glycoprotein) and adenosine-triphosphate-binding cassette sub-family C member 1 (ABCC1; multidrug resistance protein 1), two proteins first described in multidrug resistant tumors, physiologically transport several immune mediators and are required for the adequate functioning of the immune system, we aimed to measure the expression and activity of these proteins in peripheral blood mononuclear cells (PBMC), thymocytes, and also kidneys of normotensive Wistar Kyoto rats and SHR. Our results showed that ABCB1, but not ABCC1, activity was diminished (nearly 50%) in PBMC. Moreover, Abcb1b gene was downregulated in PBMC and kidney of SHR and this was not counterbalanced by an upregulation of its homolog Abcb1a, suggesting that the diminished activity is due to downregulation of the gene. No alteration was detected in ABCB1 activity in SHR thymocytes, indicating that this downregulation occurs after lymphocytes leave the primary lymphoid organs. Even though it is not known at present which parameter(s) is(are) responsible for this downregulation, it may contribute for the altered immune response observed in hypertension and to possible altered drug disposition in hypertensive individuals, resulting in greater drug interaction and increased drug toxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057958     DOI: 10.1007/s00424-007-0397-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  62 in total

1.  Lymphocyte subpopulations in pregnancy complicated by hypertension.

Authors:  Fadia Mahmoud; A Omu; H Abul; S El-Rayes; D Haines
Journal:  J Obstet Gynaecol       Date:  2003-01       Impact factor: 1.246

2.  Multidrug resistance-associated protein: sequence correction.

Authors:  S P Cole; R G Deeley
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

Review 3.  The mouse multidrug resistance gene family: structural and functional analysis.

Authors:  P Gros; E Buschman
Journal:  Int Rev Cytol       Date:  1993

4.  Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.

Authors:  G Raghu; S W Park; I B Roninson; E B Mechetner
Journal:  Exp Hematol       Date:  1996-08       Impact factor: 3.084

5.  Enhanced DNA fragmentation in the thymus of spontaneously hypertensive rats.

Authors:  H Suzuki; F A Delano; N Jamshidi; D Katz; M Mori; K Kosaki; R A Gottlieb; H Ishii; G W Schmid-Schönbein
Journal:  Am J Physiol       Date:  1999-06

6.  Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes.

Authors:  M Sukhai; A Yong; A Pak; M Piquette-Miller
Journal:  Inflamm Res       Date:  2001-07       Impact factor: 4.575

7.  FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes.

Authors:  Shaun M Honig; Shuang Fu; Xia Mao; Adam Yopp; Michael D Gunn; Gwendalyn J Randolph; Jonathan S Bromberg
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts.

Authors:  D Ba; N Takeichi; T Kodama; H Kobayashi
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

9.  Tissue distribution of the multidrug resistance protein.

Authors:  M J Flens; G J Zaman; P van der Valk; M A Izquierdo; A B Schroeijers; G L Scheffer; P van der Groep; M de Haas; C J Meijer; R J Scheper
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

10.  Analysis of P-glycoprotein-mediated membrane transport in human peripheral blood lymphocytes using the UIC2 shift assay.

Authors:  Suk W Park; Noureddine Lomri; Luiz A Simeoni; John P Fruehauf; Eugene Mechetner
Journal:  Cytometry A       Date:  2003-06       Impact factor: 4.355

View more
  6 in total

1.  Ouabain-induced alterations in ABCB1 of mesenteric lymph nodes and thymocytes of rats and mice.

Authors:  Daniel Boff Lima; Raphael Carmo Valente; Marcia Alves Marques Capella
Journal:  Oncol Lett       Date:  2016-11-08       Impact factor: 2.967

2.  Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo.

Authors:  Han Li; Zhang Yan; Wang Ning; Guo Xiao-Juan; Zang Cai-Hong; Jiang Jin-Hua; Ma Fang; Wang Qing-Duan
Journal:  J Biomed Biotechnol       Date:  2011-06-30

3.  Entry of antiepileptic drugs (valproate and lamotrigine) into the developing rat brain.

Authors:  Samuel J Toll; Fiona Qiu; Yifan Huang; Mark D Habgood; Katarzyna M Dziegielewska; Shuai Nie; Norman R Saunders
Journal:  F1000Res       Date:  2021-05-13

4.  ABCC1 is related to the protection of the distal nephron against hyperosmolality and high sodium environment: possible implications for cancer chemotherapy.

Authors:  Leonardo M Fonseca; Adriana B Alvarez; Rachel C Rodrigues; Diego H F Santos; Anibal G Lopes; Marcia A M Capella
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

5.  Co-expression of pregnane X receptor and ATP-binding cassette sub-family B member 1 in peripheral blood: A prospective indicator for drug resistance prediction in non-small cell lung cancer.

Authors:  Qingnuan Kong; Zenglei Han; Xiaoli Zuo; Hongjun Wei; Weiqing Huang
Journal:  Oncol Lett       Date:  2016-03-22       Impact factor: 2.967

6.  Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis.

Authors:  João Marcos de Azevedo Delou; Giselle Maria Vignal; Vanessa Índio-do-Brasil; Maria Theresa de Souza Accioly; Taiana Sousa Lopes da Silva; Diogo Nascimento Piranda; Marcelo Sobral-Leite; Marcelo Alex de Carvalho; Márcia Alves Marques Capella; Rosane Vianna-Jorge
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.